Torthaí cuardaigh - Jan Steffel
- 1 - 20 toradh as 49 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism de réir Jan Steffel, Eugene Braunwald
Foilsithe / Cruthaithe 2011Revisão -
2
Superresponse to Cardiac Resynchronization Therapy de réir Jan Steffel, Frank Ruschitzka
Foilsithe / Cruthaithe 2014Artigo -
3
Sweet and Sour de réir Thomas F. Lüscher, Jan Steffel
Foilsithe / Cruthaithe 2008Carta -
4
Tissue Factor in Cardiovascular Diseases de réir Jan Steffel, Thomas F. Lüscher, Felix C. Tanner
Foilsithe / Cruthaithe 2006Revisão -
5
Electrocardiographic Characteristics at Initial Diagnosis in Patients With Isolated Left Ventricular Noncompaction de réir Jan Steffel, Richard Kobza, Erwin Oechslin, Rolf Jenni, Fırat Duru
Foilsithe / Cruthaithe 2009Artigo -
6
Histamine Induces Tissue Factor Expression de réir Jan Steffel, Alexander Akhmedov, Helen Greutert, Thomas F. Lüscher, Felix C. Tanner
Foilsithe / Cruthaithe 2005Artigo -
7
Leadless pacemaker implantation via the internal jugular vein de réir Nadine Molitor, Shmaila Saleem‐Talib, Hemanth Ramanna, Daniel Höfer, Alexander Breitenstein, Jan Steffel
Foilsithe / Cruthaithe 2024Artigo -
8
Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy de réir S. Schmidt, David Hürlimann, Christoph Starck, G Hindricks, Thomas F. Lüscher, Frank Ruschitzka, Jan Steffel
Foilsithe / Cruthaithe 2013Artigo -
9
Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage de réir Christoph Starck, Jan Steffel, Maximilian Y. Emmert, André Plass, S. Mahapatra, Volkmar Falk, Sacha P. Salzberg
Foilsithe / Cruthaithe 2012Artigo -
10
The COMPASS Trial de réir Jan Steffel, John W. Eikelboom, Sonia S. Anand, Olga Shestakovska, Salim Yusuf, Keith A.A. Fox
Foilsithe / Cruthaithe 2020Artigo -
11
Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH <sub>2</sub> Kinase Phosphorylation de réir Jan Steffel, Matthias Hermann, Helen Greutert, Steffen Gay, Thomas F. Lüscher, Frank Ruschitzka, Felix C. Tanner
Foilsithe / Cruthaithe 2005Artigo -
12
-
13
Drug-Eluting Stent and Coronary Thrombosis de réir Thomas F. Lüscher, Jan Steffel, Franz R. Eberli, Michael Joner, Gaku Nakazawa, Felix C. Tanner, Renu Virmani
Foilsithe / Cruthaithe 2007Revisão -
14
The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial de réir Valentina A. Rossi, Anne‐Christin Stoewhas, Giovanni Camen, Jan Steffel, Konrad E. Bloch, John Stradling, Marianne Køhler
Foilsithe / Cruthaithe 2012Artigo -
15
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling de réir Georg Fröhlich, Jan Steffel, David Hürlimann, Frank Enseleit, Thomas F. Lüscher, Frank Ruschitzka, William T. Abraham, Johannes Holzmeister
Foilsithe / Cruthaithe 2010Artigo -
16
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents de réir Giovanni G. Camici, Jan Steffel, I. Amanovic, Alexander Breitenstein, Jeannette Baldinger, Stephan Sylvest Keller, Thomas F. Lüscher, Felix C. Tanner
Foilsithe / Cruthaithe 2009Artigo -
17
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systemati... de réir Neal A. Chatterjee, Attila Róka, Steven A. Lubitz, Michael R. Gold, Claude Daubert, Cecilia Linde, Jan Steffel, G. André Ng, Theofanie Mela
Foilsithe / Cruthaithe 2015Revisão -
18
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial de réir Jan Steffel, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, Dan Atar, Hein Heidbüchel, A. John Camm, Elliott M. Antman, Christian T. Ruff
Foilsithe / Cruthaithe 2015Artigo -
19
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation de réir Jan Steffel, Christian T. Ruff, Ophelia Yin, Eugene Braunwald, Jeong‐Gun Park, Sabina A. Murphy, Stuart J. Connolly, Elliott M. Antman, Robert P. Giugliano
Foilsithe / Cruthaithe 2021Artigo -
20
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling de réir Jan Steffel, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, Michele Mercuri, Youngsook Choi, Philip E. Aylward, Harvey D. White, Josè Luis Zamorano, Elliott M. Antman, Christian T. Ruff
Foilsithe / Cruthaithe 2016Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Cardiology
Atrial fibrillation
Warfarin
Intensive care medicine
Engineering
Mechanical engineering
Stroke (engine)
Heart failure
Cardiac resynchronization therapy
Confidence interval
Ejection fraction
Myocardial infarction
Surgery
Vitamin K antagonist
Biology
Randomized controlled trial
Anesthesia
Coagulation
Disease
Edoxaban
Endocrinology
Hazard ratio
Heart Rhythm
Physics
Receptor
Rivaroxaban
Tissue factor
Cell biology